...
首页> 外文期刊>International Journal of Pharmaceutics >Innovative intragastric ascaridole floating tablets: Development, optimization, and in vitro-in vivo evaluation
【24h】

Innovative intragastric ascaridole floating tablets: Development, optimization, and in vitro-in vivo evaluation

机译:创新的胃内scar虫油漂浮片:开发,优化和体外-体内评估

获取原文
获取原文并翻译 | 示例
           

摘要

Gastro-floating tablets of ascaridole, a volatile oil were developed to prolong the gastric residence time and thereby, enhance local therapeutic efficacy. The tablets were optimized and prepared by direct compression techniques using hydroxypropylmethylcellulose (HPMC K15M) and polyethylene oxide (PEO WSRN-750) as hydrophilic matrices and calcium carbonate (CaCO3) as a gas-generating agent. In vitro evaluation of the prepared tablets was performed by determining the hardness, friability, content uniformity, and weight variation. In addition, floating lag time, total floating time, and drug release behavior were evaluated. Finally, optimized tablets were subjected to stability and in vivo gamma scintigraphy studies. Results showed that the formulated tablets were white, smooth, and flat in appearance and met the Chinese Pharmacopoeia (ChP) criteria for weight variation, drug content, and friability. The tablets had satisfactory buoyancy and sustained drug release profile that followed non-Fickian kinetics. In vivo gamma scintigraphy suggests that the floating tablet did not adhere to the stomach mucous but were retained in the stomach for extended periods of 5.80 +/- 0.50 h following administration, indicating that gastro retentive time of ascaridole tablets increased owing to the floating principle. (C) 2015 Elsevier B.V. All rights reserved.
机译:研制出了蛇麻油(一种挥发油)的胃浮片剂,以延长其在胃中的停留时间,从而提高局部治疗效果。通过使用羟丙基甲基纤维素(HPMC K15M)和聚环氧乙烷(PEO WSRN-750)作为亲水性基质以及碳酸钙(CaCO3)作为产气剂的直接压片技术对片剂进行优化和制备。通过确定硬度,脆性,含量均匀性和重量变化来对制备的片剂进行体外评估。另外,评估了漂浮滞后时间,总漂浮时间和药物释放行为。最后,对优化的片剂进行稳定性和体内γ闪烁显像研究。结果表明,所配制的片剂外观为白色,光滑且扁平,并且符合中国药典(ChP)的重量变化,药物含量和易碎性标准。该片剂具有令人满意的浮力,并遵循非菲克动力学原理持续释放药物。体内伽玛闪烁显像表明,漂浮片剂在给药后未粘附于胃粘膜,但在胃中保留了5.80 +/- 0.50 h的较长时间,这表明由于漂浮原理,a草啶片剂的胃滞留时间增加了。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号